Specifically, within NSCLC data, a robust negative correlation was observed between PRMT3 expression and the presence of CD8+ T cells, with lower infiltration of these cells in tumors exhibiting higher PRMT3 levels (Fig. 4C). This evidence concerns the gene PRMT3 and non-small cell lung carcinoma.